Addiction

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System

HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced…

2 years ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice…

2 years ago

ACMHCK and KDADS Select Netsmart to Propel Statewide Integration of CCBHCs in Kansas

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#BehavioralHealth--The Association of Community Mental Health Centers of Kansas (ACMHCK) has chosen Netsmart and its industry-leading Population…

2 years ago

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

Highly Experienced Pharma Commercial and Business Development Executive in Addiction Treatment Space Joins Leadership Team While Continuing as Board MemberCharlottesville,…

2 years ago

Luxury Addiction Rehab Expands Services Amid Rebranding

Private addiction and dual diagnosis treatment center Annandale Behavioral Health develops a comprehensive continuum of care for drug and alcohol…

2 years ago

Advanced Addiction Center Announces Grand Opening of New Outpatient Center on January 13, 2024

New Era in Addiction Recovery: Advanced Addiction Center to Unveil State-of-the-Art Outpatient Facility on January 13, 2024MEDFORD, MA / ACCESSWIRE…

2 years ago

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

JACKSON CENTER, PA / ACCESSWIRE / January 11, 2024 / Halberd Corporation (OTC PINK:HALB) made significant advances in its technology…

2 years ago

Nexalin Technology Unveils Next-Generation HALO™ Clarity

HALO™ Clarity headset Photo: HALO™ Clarity headset A new neurostimulation device to combat the growing global mental health epidemic Designed…

2 years ago

CORRECTION BY SOURCE: Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Correction: The initial release stated Mr. Peter Croden was previously Global President of Upjohn/Pfizer Animal Health Division in Germany. The…

2 years ago

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

2 years ago